$MNKD Recent Headlines 7 gut checks before the s
Post# of 94145
7 gut checks before the stock market's opening bell 5:25 a.m. Aug. 15, 2013 - Shawn Langlois
On a mixed day, two biopharma firms' insulin drugs vie for investors 10:41 a.m. June 19, 2013 - Russ Britt
MannKind shares leap as web site says firm is a ripe takeover target 12:32 p.m. May 22, 2013 - Russ Britt
MannKind up 6.9% in premarket 7:43 a.m. Jan. 2, 2013 - Steve Gelsi
MannKind prices offering at 23% discount 9:04 a.m. Oct. 18, 2012 - MarketWatch.com
MannKind down 25% in premarket 7:59 a.m. Oct. 18, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Hot stocks to watch 6:39 a.m. Sept. 4, 2012 - MarketWatch.com
MannKind in development pact valued up to $130M 6:02 a.m. April 30, 2012 - MarketWatch.com
Stocks to watch Thursday: Diamond Foods, Six Flags 6:59 a.m. Feb. 9, 2012 - MarketWatch
Friday’s biggest gaining & declining stocks 4:48 p.m. Feb. 3, 2012 - Kate Gibson
MannKind prices units offering at 2.8% discount 12:00 p.m. Feb. 3, 2012 - MarketWatch.com
Mannkind sinks 14% on public offering 11:47 a.m. Jan. 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining & declining stocks 4:28 p.m. Aug. 12, 2011 - Sue Chang
Tuesday’s biggest gaining and declining stocks 3:23 p.m. May 10, 2011 - Kate Gibson
BioMimetic, InterMune drop in afternoon trading 1:59 p.m. May 10, 2011 - Val Brickates Kennedy
Tenet, Community Health fall after hours 6:04 p.m. May 9, 2011 - Carla Mozee
Stocks to watch Tuesday: Disney, McDermott 5:34 p.m. May 9, 2011 - Wallace Witkowski
MannKind awaiting more details from FDA on Afrezza 4:33 p.m. May 9, 2011 - Sue Chang
Depomed slides as drug stocks fall; Mannkind soars 11:36 a.m. Feb. 15, 2011 - Val Brickates Kennedy
MannKind Corporation's CEO Discusses Q4 2013 Results - Earnings Call Transcript 7:12 p.m. Feb. 18, 2014 - Seeking Alpha
MannKind Corporation Discusses Q4 2013 Results (Webcast) 4:55 p.m. Feb. 18, 2014 - Seeking Alpha
Significant Upcoming Catalysts For These Biotechs Should Provide Alpha Opportunity 8:30 a.m. Feb. 14, 2014 - Seeking Alpha
Interesting MNKD Put And Call Options For March 28th 11:33 a.m. Feb. 13, 2014 - TheStreet.com
Is There Investment Upside In The Future Of Treating Diabetes? 8:01 a.m. Feb. 10, 2014 - Seeking Alpha
Biotech Stock Mailbag: Furiex, La Jolla Pharma, Sarepta 6:00 a.m. Feb. 7, 2014 - TheStreet.com
MNKD June 21st Options Begin Trading 11:58 a.m. Feb. 6, 2014 - TheStreet.com
Interesting MNKD Put And Call Options For March 7th 11:34 a.m. Jan. 30, 2014 - TheStreet.com
Oramed's Data Will Define A New Standard For Diabetes 7:48 a.m. Jan. 28, 2014 - Seeking Alpha
'Mad Money' Lightning Round: Buy, Buy, Buy Chevron 6:00 a.m. Jan. 28, 2014 - TheStreet.com
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Jan. 28, 2014 - Seeking Alpha
Cramer's Lightning Round - Mannkind Is Too Hot For The Touch (1/27/14) 5:10 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Market Reset 8:33 p.m. Jan. 27, 2014 - TheStreet.com
First Week Of March 22nd Options Trading For MannKind (MNKD) 11:28 a.m. Jan. 23, 2014 - TheStreet.com
MannKind Catalysts: Insights About Diabetes Care Metrics And Long-Term Complications 5:45 p.m. Jan. 22, 2014 - Seeking Alpha
3 Small Biotech Companies Poised For Big Growth In 2014 1:07 p.m. Jan. 21, 2014 - Seeking Alpha
Why MannKind Is My 2014 Short Pick In Healthcare 1:58 p.m. Jan. 17, 2014 - Seeking Alpha
J.P. Morgan Healthcare Confab Live Blog: Day Three 10:12 a.m. Jan. 15, 2014 - TheStreet.com
Biotech Stock Roundup: Intercept Pharma Grabs the Limelight - Analyst Blog 9:31 a.m. Jan. 15, 2014 - Zacks.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Jan. 15, 2014 - InvestorPlace.com
MannKind Corporation to Present at Upcoming Conferences 8:00 a.m. Today - GlobeNewswire
Critical Alerts For SolarCity, Qualcomm, Bed Bath & Beyond, MannKind, and Groupon Released By InvestorsObserver 9:31 a.m. Feb. 18, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2013 Fourth Quarter and Full Year Financial Results 8:02 a.m. Feb. 18, 2014 - GlobeNewswire
MannKind Corporation to Hold 2013 Fourth Quarter and Full Year Financial Results Conference Call on February 18, 2014 10:48 p.m. Feb. 4, 2014 - GlobeNewswire
Critical Alerts For BP, Yum Brands, MannKind, US Bancorp, and Lululemon Released By InvestorsObserver 9:31 a.m. Jan. 16, 2014 - PR Newswire - PRF
MannKind Announces Tentative Date of FDA Advisory Committee Review of AFREZZA 6:00 a.m. Jan. 10, 2014 - GlobeNewswire
MannKind Corporation to Present at the J.P. Morgan 2014 Healthcare Conference 5:00 p.m. Jan. 8, 2014 - GlobeNewswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 8:00 a.m. Dec. 31, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Share Price Movements and Clinical Studies - Research Report on Celldex Therapeutics, Envision, MannKind, Covance, and Auxilium 8:00 a.m. Dec. 19, 2013 - PR Newswire
Stock Price Updates - Research Report on AbbVie, Covance, MannKind, MAKO Surgical, and Envision 8:00 a.m. Dec. 11, 2013 - PR Newswire
Final Hour Buzz: Gilead Sciences, MannKind Corporation, Facebook Inc, Tiger Oil and Energy 2:46 p.m. Dec. 10, 2013 - ACCESSWIRE
Announcements and Sponsorships by Biotechnology Companies and Major Drug Manufacturers - Research Report on Lilly, Geron, MannKind, Techne, and InterMune 8:00 a.m. Dec. 2, 2013 - PR Newswire
MannKind Corporation to Present at The Piper Jaffray 25th Annual Healthcare Conference 5:00 p.m. Nov. 27, 2013 - BusinessWire
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
MannKind Corporation to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 5:00 p.m. Nov. 7, 2013 - BusinessWire
Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind 8:00 a.m. Nov. 6, 2013 - PR Newswire
MannKind Corporation Reports 2013 Third Quarter Financial Results 9:00 a.m. Nov. 4, 2013 - BusinessWire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 12:30 p.m. Nov. 1, 2013 - PR Newswire